News Quantified

TTOO – t2 biosystems, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

T2 Biosystems, Inc. (NASDAQ: TTOO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $12.00 to $3.00. They now have a "hold" rating on the stock.

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

T2 Biosystems shareholders vote to convert $15M CRG debt into equity [Seeking Alpha]

T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity

T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. [Yahoo! Finance]

Canaccord Genuity

Form S-1 T2 Biosystems, Inc.

Form SC 13D T2 Biosystems, Inc. Filed by: CR Group L.P.

Form 8-K T2 Biosystems, Inc. For: Apr 12

Form 4 T2 Biosystems, Inc. For: Apr 12 Filed by: CR Group L.P.

Form 8-K T2 Biosystems, Inc. For: Apr 11

Top News Gainers

9/10 Form 8-K T2 Biosystems, Inc. For: Sep 06 82.5%

3/18 Form 4 T2 Biosystems, Inc. For: Mar 14 Filed by: Pare Anthony 34.3%

2/27 Form 8-K T2 Biosystems, Inc. For: Feb 24 27.1%

9/3 IBN, I among premarket losers [Seeking Alpha] 24.2%

3/24 T2 Biosystems Announces Preliminary First Quarter 2020 Financial Results 20.7%

4/15 T2 Biosystems Reports Granting of Inducement Award 20.1%

9/11 T2 Biosystems Inc (NASDAQ: TTOO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $3.50 price target on the stock, up previously from $2.50. 18.5%

11/15 T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum 16.6%

3/16 Form 10-K T2 Biosystems, Inc. For: Dec 31 15.7%

8/6 T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS 13.9%

Top News Decliners

7/30 T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update -58.7%

11/12 T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update -29.1%

3/25 The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down [Yahoo! Finance News] -25.5%

2/24 Q4/2019 12/31/2019 EPS -0.300 ZacksConsensus -0.270 ActVsEst (0.030) - Miss -21.8%

12/13 T2 Biosystems Reports Granting of Inducement Awards -16.5%

11/13 T2 Biosystems Inc (NASDAQ: TTOO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $3.00 price target on the stock. -15.5%

1/31 T2 Biosystems Inc (NASDAQ: TTOO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.2%

2/25 Form 4 T2 Biosystems, Inc. For: Feb 21 Filed by: Lowery Thomas J. -14.9%

11/14 C. Auris, The Deadly Fungus CDC Says It’s “Still Trying To Figure Out?” [Forbes] -13.2%

3/10 Form 8-K T2 Biosystems, Inc. For: Mar 09 -11.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day